FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
Malaysian Reserve4 小时
Bowtie Collaborate with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to Promote ...
Aims to boost health awareness for migraine, disease impacting over 900,000 Hongkongers HONG KONG, Feb. 7, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first ...